Lawmakers propose plan to protect provider access to 340B Program drugs
Pharmaceutical manufacturers would be prohibited from interfering with the ability of providers to receive prescription drugs if contracted with the 340B program, under a plan filed last week in Springfield.
To access this content, you must purchase 1 Year Health News Illinois Subscription or 1 Year Group Subscription - Up to 5 Users, or log in if you are a member.
